Prosecution Insights
Last updated: October 02, 2026

Shenzhen Fangshengtai Medical Technology Co. Ltd.

Technology area: Biotechnology & Pharmaceuticals

1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready

Analysis

Shenzhen Fangshengtai Medical Technology Co. Ltd. is active in the Biotechnology & Pharmaceuticals technology area with 1 pending office action currently in progress. This action is assigned to 1 distinct examiner, reflecting a focused prosecution docket at the USPTO. The activity is contained within 1 distinct art unit, indicating a specific technical scope for the company's pending application.

CRAIGO, WILLIAM A is the busiest examiner for the portfolio, responsible for 1 busiest examiner pending office action. With only 1 distinct examiner involved, the prosecution path is highly dependent on the individual standards of CRAIGO, WILLIAM A. Practitioners should tailor their strategy to the specific preferences of this examiner to successfully resolve the 1 pending office action. The alignment of 1 distinct examiner with 1 distinct art unit suggests a very specialized technical focus.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

1
Total Pending OAs
0
Non-Final OAs
0
Final Rejections
1
Advisory / Quayle

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

0
Hard (0%)
1
Medium (100%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§103 only1 (100%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

1
Life Sciences
100% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

10 h
Manual time on pending OAs
2 h
Time saved (low, 20%)
4 h
Time saved (mid, 35%)
0.1 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
CRAIGO, WILLIAM A 1 49.2% +38.2%

Interview Candidates (1)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18258518 METHOD FOR TREATING PAIN USING VANADIUM COMPOUNDS CRAIGO, WILLIAM A —

Top Art Units

Art UnitApps
1615 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18258518 METHOD FOR TREATING PAIN USING VANADIUM COMPOUNDS CRAIGO, WILLIAM A 1615 §103 Non-Final OA — Pending Jun 20, 2023

Managing Shenzhen Fangshengtai Medical Technology Co. Ltd.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month